In the news
Will gene therapy change the treatment of muscular dystrophy?
June 8, 2021Related news
In the news
April 18, 2024
Dr. YuQian Liu Investigates the Future Benefits of Cell, Gene Therapies Using Real-World Data
American Journal of Managed Care (AJMC): YuQian Liu, PharmD, Magellan Rx Management, explores the current space of cell and gene therapies based on real-world data and potential emerging therapies in the future, while expanding upon long-term efficacy concerns.
In the news
April 18, 2024
Multiple Sclerosis Generics Switching Program Saves Millions
Specialty Pharmacy Continuum: A program in which managed care pharmacists reached out to healthcare providers in 2023 to advise them of potential cost savings that could accrue by switching their patients with multiple sclerosis (MS) from branded to generic therapies has generated significant savings
In the news
April 16, 2024
Prime Study Finds Lower Adherence, Higher Costs for Weight Loss Drugs | AMCP 2024
Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime Therapeutics/MagellanRx Management poster at AMCP 2024